14.2 Citric Acid Cycle, Mitochondrial Electron Transport, Oxidative Phosphorylation, and $\beta$-Oxidation

Key Takeaways

  • The Pyruvate Dehydrogenase Complex (PDC) catalyzes the irreversible oxidative decarboxylation of pyruvate to acetyl-CoA using three enzymes (E1,E2,E3E_1, E_2, E_3) and five cofactors (TPP, lipoamide, CoA-SH, FAD, NAD+\text{NAD}^+); it is inactivated by PDC kinase phosphorylation and inhibited by arsenite binding to lipoamide dithiols.

  • One complete turn of the Citric Acid Cycle (TCA cycle) oxidizes one acetyl-CoA, producing 3 NADH3\text{ NADH}, 1 FADH21\text{ FADH}_2, 1 GTP1\text{ GTP} (via substrate-level phosphorylation by succinyl-CoA synthetase), and 2 CO22\text{ CO}_2; succinate dehydrogenase is an integral inner membrane enzyme serving simultaneously as Complex II of the ETC.

  • The mitochondrial Electron Transport Chain transfers electrons from NADH\text{NADH} through Complexes I, III, and IV, pumping 10 H+10\text{ H}^+ into the intermembrane space; electrons from FADH2\text{FADH}_2 enter at Complex II and traverse Complexes III and IV, pumping 6 H+6\text{ H}^+.

  • The chemiosmotic hypothesis states that the proton-motive force (Δp=Δψ−2.303RTFΔpH≈220 mV\Delta p = \Delta\psi - \frac{2.303 RT}{F}\Delta\text{pH} \approx 220\text{ mV}) drives ATP synthesis via the FoF1F_oF_1 ATP synthase, operating via Paul Boyer's rotational binding-change mechanism with P/O ratios of 2.52.5 for NADH\text{NADH} and 1.51.5 for FADH2\text{FADH}_2.

  • Respiratory chain inhibitors (cyanide, CO, azide blocking Complex IV; antimycin A blocking Complex III; rotenone blocking Complex I) halt both electron transport and ATP synthesis, whereas uncouplers (2,4-DNP, UCP-1/thermogenin) dissipate the proton gradient, collapsing ATP synthesis while stimulating respiration and generating heat.

Last updated: October 2026

14.2 Citric Acid Cycle, Mitochondrial Electron Transport, Oxidative Phosphorylation, and β\beta-Oxidation

Quick Answer: The mitochondrial matrix and inner mitochondrial membrane host the terminal oxidative machinery of the cell. The pyruvate dehydrogenase complex (PDC) oxidatively decarboxylates pyruvate into acetyl-CoA, coupling glycolysis to the citric acid cycle using five distinct coenzymes (TPP, lipoic acid, CoA, FAD, NAD+\text{NAD}^+). Each acetyl-CoA entering the citric acid cycle yields 3 NADH3\text{ NADH}, 1 FADH21\text{ FADH}_2, 1 GTP1\text{ GTP} (substrate-level phosphorylation), and 2 CO22\text{ CO}_2. Electrons from NADH\text{NADH} and FADH2\text{FADH}_2 traverse the electron transport chain (ETC) to reduce O2O_2 to H2OH_2O, pumping protons across the inner mitochondrial membrane (10 H+10\text{ H}^+ per NADH\text{NADH}, 6 H+6\text{ H}^+ per FADH2\text{FADH}_2). The resulting proton-motive force (≈220 mV\approx 220\text{ mV}) drives rotational ATP synthesis by the FoF1F_oF_1 ATP synthase, yielding 2.5 ATP2.5\text{ ATP} per NADH\text{NADH} and 1.5 ATP1.5\text{ ATP} per FADH2\text{FADH}_2. Complete oxidation of glucose yields 30−32 ATP30-32\text{ ATP} depending on whether the glycerol-3-phosphate or malate-aspartate shuttle is used. Fatty acids are activated to acyl-CoA, translocated via the carnitine shuttle (inhibited by malonyl-CoA), and degraded through the 4-step β\beta-oxidation spiral, yielding 106 net ATP106\text{ net ATP} from palmitate (C16C_{16}). Under carbohydrate deprivation, excess acetyl-CoA is shunted to ketone bodies, which fuel the heart and brain but cannot be consumed by the liver.


The Pyruvate Dehydrogenase Complex (PDC)

Pyruvate produced by glycolysis in the cytosol enters the mitochondrial matrix via the mitochondrial pyruvate carrier (MPC, a proton-symporter). In the matrix, pyruvate undergoes irreversible oxidative decarboxylation to acetyl-CoA catalyzed by the Pyruvate Dehydrogenase Complex (PDC):

Pyruvate+CoA-SH+NAD+→PDCAcetyl-CoA+CO2+NADH+H+\text{Pyruvate} + \text{CoA-SH} + \text{NAD}^+ \xrightarrow{\text{PDC}} \text{Acetyl-CoA} + \text{CO}_2 + \text{NADH} + \text{H}^+ ΔG∘′=−33.4 kJ/mol\Delta G^{\circ\prime} = -33.4\text{ kJ/mol}

This reaction represents the critical metabolic bridge connecting carbohydrate catabolism to the citric acid cycle and lipid biosynthesis. It is strictly irreversible in animals; acetyl-CoA cannot be converted back into pyruvate or glucose.

Subunit Composition and the Five Coenzymes

The PDC is a massive non-covalent multienzyme assembly (Mr≈4.5 to 10×106 DaM_r \approx 4.5\text{ to } 10\times 10^6\text{ Da}) comprising multiple copies of three catalytic enzymes and five specialized coenzymes:

SubunitEnzyme NameProsthetic Group / CoenzymePrimary Function in Mechanism
E1E_1Pyruvate DehydrogenaseThiamine Pyrophosphate (TPP)Decarboxylates pyruvate, forming a hydroxyethyl-TPP carbanion intermediate
E2E_2Dihydrolipoyl TransacetylaseLipoamide (prosthetic) and Coenzyme A (substrate)Oxidizes hydroxyethyl group to acetyl group; transfers acetyl to CoA, forming Acetyl-CoA and dihydrolipoamide
E3E_3Dihydrolipoyl DehydrogenaseFAD (prosthetic) and NAD+\text{NAD}^+ (substrate)Re-oxidizes reduced dihydrolipoamide back to lipoamide disulfide; transfers electrons to NAD+\text{NAD}^+ via FAD\text{FAD}
PDC Five-Step Catalytic Cycle:
  1. E1: Pyruvate + TPP  -->  Hydroxyethyl-TPP + CO2
  2. E1/E2: Hydroxyethyl-TPP + Lipoamide(S-S)  -->  Acetyllipoamide(S-Ac, SH) + TPP
  3. E2: Acetyllipoamide + CoA-SH  -->  Acetyl-CoA + Dihydrolipoamide(SH, SH)
  4. E3: Dihydrolipoamide(SH, SH) + E3-[FAD]  -->  Lipoamide(S-S) + E3-[FADH2]
  5. E3: E3-[FADH2] + NAD+  -->  E3-[FAD] + NADH + H+
  • The Swinging Lipoamide Arm: The lipoyl group of E2E_2 is covalently bound via an amide linkage to the ε\varepsilon-amino group of a specific lysine residue, creating a flexible 14 A˚14\text{ \AA} long hydrocarbon "swinging arm". This arm visits the active site of E1E_1 to receive the acetyl group, transfers it to CoA in the E2E_2 core, and swings to E3E_3 to be re-oxidized by FAD.
  • The Chemical Paradox of E3E_3: Standard reduction potentials dictate that electrons normally flow from lower to higher E∘′E^{\circ\prime}. Free FAD/FADH2\text{FAD}/\text{FADH}_2 has E∘′≈−0.22 VE^{\circ\prime} \approx -0.22\text{ V}, whereas NAD+/NADH\text{NAD}^+/\text{NADH} has E∘′=−0.32 VE^{\circ\prime} = -0.32\text{ V}. In E3E_3, the local protein environment alters the reduction potential of the enzyme-bound FAD to approximately −0.34 V-0.34\text{ V}, allowing electron transfer from FADH2\text{FADH}_2 to NAD+\text{NAD}^+ to proceed favorably!

Regulation and Clinical Toxicology of PDC

  1. Allosteric Feedback: PDC is allosterically inhibited by its direct products: acetyl-CoA (inhibits E2E_2) and NADH\text{NADH} (inhibits E3E_3).
  2. Covalent Phosphorylation (PDC Kinase vs. PDC Phosphatase):
    • PDC Kinase: Phosphorylates three specific Ser residues on E1E_1, completely inactivating the complex. PDC kinase is activated by high energy indicators (high [ATP]/[ADP][\text{ATP}]/[\text{ADP}], [NADH]/[NAD+][\text{NADH}]/[\text{NAD}^+], and [Acetyl-CoA]/[CoA][\text{Acetyl-CoA}]/[\text{CoA}]) and inhibited by pyruvate and ADP.
    • PDC Phosphatase: Hydrolyzes the serine phosphate groups, reactivating PDC. It is activated by Ca2+\text{Ca}^{2+} (signaling muscle contraction) and insulin (in adipocytes).
  3. Arsenite and Heavy Metal Poisoning: Arsenite (AsO33−\text{AsO}_3^{3-}) and mercury compounds bind with high affinity to the vicinal sulfhydryl groups (dithiols) of reduced dihydrolipoamide, forming a stable cyclic thioarsenite chelate ring. This permanently arrests E2E_2 turnover, halting both the PDC and the α\alpha-ketoglutarate dehydrogenase complex, starving the brain of aerobic ATP and causing central nervous system pathology.

The Citric Acid Cycle (Krebs Cycle / TCA Cycle)

The citric acid cycle is an amphibolic pathway that completely oxidizes the two-carbon acetyl unit of acetyl-CoA into two molecules of CO2\text{CO}_2.

The Eight Enzymatic Reactions

StepEnzymeReaction TypeReactants →\rightarrow ProductsΔG∘′\Delta G^{\circ\prime} (kJ/mol)Mechanistic & Regulatory Notes
1Citrate SynthaseAldol condensation / Thioester hydrolysisAcetyl-CoA+OAA+H2O→Citrate+CoA-SH\text{Acetyl-CoA} + \text{OAA} + \text{H}_2\text{O} \rightarrow \text{Citrate} + \text{CoA-SH}−32.2-32.2Committed entry step; inhibited by ATP, NADH, succinyl-CoA, citrate
2AconitaseDehydration / RehydrationCitrate⇌cis-Aconitate⇌Isocitrate\text{Citrate} \rightleftharpoons \text{cis-Aconitate} \rightleftharpoons \text{Isocitrate}+13.3+13.3[4Fe−4S][4\text{Fe}-4\text{S}] iron-sulfur cluster; inhibited by fluorocitrate
3Isocitrate DehydrogenaseOxidative decarboxylationIsocitrate+NAD+→α-KG+CO2+NADH+H+\text{Isocitrate} + \text{NAD}^+ \rightarrow \alpha\text{-KG} + \text{CO}_2 + \text{NADH} + \text{H}^+−20.9-20.9Rate-limiting step; Mn2+^{2+}; activated by ADP/Ca2+^{2+}, inhibited by ATP/NADH
4α\alpha-Ketoglutarate DehydrogenaseOxidative decarboxylationα-KG+CoA-SH+NAD+→Succinyl-CoA+CO2+NADH+H+\alpha\text{-KG} + \text{CoA-SH} + \text{NAD}^+ \rightarrow \text{Succinyl-CoA} + \text{CO}_2 + \text{NADH} + \text{H}^+−33.5-33.5Multienzyme complex identical to PDC; inhibited by Succinyl-CoA, NADH
5Succinyl-CoA SynthetaseSubstrate-level phosphorylationSuccinyl-CoA+GDP+Pi⇌Succinate+GTP+CoA-SH\text{Succinyl-CoA} + \text{GDP} + \text{P}_i \rightleftharpoons \text{Succinate} + \text{GTP} + \text{CoA-SH}−2.9-2.9Phospho-histidine intermediate; only substrate-level phosphorylation in TCA
6Succinate DehydrogenaseDehydrogenationSuccinate+FAD⇌Fumarate+FADH2\text{Succinate} + \text{FAD} \rightleftharpoons \text{Fumarate} + \text{FADH}_20.00.0Complex II of ETC; covalent FAD, 3 Fe-S centers; inhibited by malonate
7FumaraseHydrationFumarate+H2O⇌L-Malate\text{Fumarate} + \text{H}_2\text{O} \rightleftharpoons \text{L-Malate}−3.8-3.8Stereospecific trans-addition of water across double bond
8Malate DehydrogenaseOxidationL-Malate+NAD+⇌Oxaloacetate+NADH+H+\text{L-Malate} + \text{NAD}^+ \rightleftharpoons \text{Oxaloacetate} + \text{NADH} + \text{H}^++29.7+29.7Endothermic; pulled forward by low [OAA]<10−6 M[\text{OAA}] < 10^{-6}\text{ M} from citrate synthase

Net Stoichiometry per Acetyl-CoA

Acetyl-CoA+3NAD++FAD+GDP+Pi+2H2O⟶2CO2+3NADH+FADH2+GTP+2H++CoA-SH\text{Acetyl-CoA} + 3\text{NAD}^+ + \text{FAD} + \text{GDP} + \text{P}_i + 2\text{H}_2\text{O} \longrightarrow 2\text{CO}_2 + 3\text{NADH} + \text{FADH}_2 + \text{GTP} + 2\text{H}^+ + \text{CoA-SH}

Notice that the two carbons released as CO2\text{CO}_2 in any single turn of the cycle are not the two carbons that just entered from acetyl-CoA; they originate from the oxaloacetate backbone (traceable via 14C^{14}\text{C}-labeling experiments).

Anaplerotic Reactions

Because the citric acid cycle is amphibolic, intermediates are constantly siphoned off for anabolic biosyntheses (e.g., α\alpha-ketoglutarate →\rightarrow glutamate; oxaloacetate →\rightarrow aspartate; succinyl-CoA →\rightarrow porphyrins and heme; citrate →\rightarrow fatty acids). To maintain catalytic flux, anaplerotic (filling-up) reactions replenish cycle intermediates:

  • Pyruvate Carboxylase: The premier anaplerotic reaction in liver and kidney: Pyruvate+HCO3−+ATP→Acetyl-CoA, BiotinOxaloacetate+ADP+Pi\text{Pyruvate} + \text{HCO}_3^- + \text{ATP} \xrightarrow{\text{Acetyl-CoA, Biotin}} \text{Oxaloacetate} + \text{ADP} + \text{P}_i
  • Glutamate Dehydrogenase: Converts glutamate into α\alpha-ketoglutarate.
  • Propionyl-CoA Carboxylase: Converts propionyl-CoA (from odd-chain fatty acids) into succinyl-CoA.

The Mitochondrial Electron Transport Chain (ETC)

The respiratory chain consists of four large multiprotein complexes embedded in the inner mitochondrial membrane (IMM) and two mobile electron carriers: coenzyme Q (ubiquinone) and cytochrome c.

Electrons flow spontaneously along a thermodynamic gradient from negative standard reduction potentials (E∘′E^{\circ\prime}) toward oxygen, the terminal electron acceptor (E∘′=+0.816 VE^{\circ\prime} = +0.816\text{ V}):

NADH (−0.32 V)⟶Complex I⟶Q (+0.045 V)⟶Complex III⟶Cyt c (+0.254 V)⟶Complex IV⟶O2 (+0.816 V)\text{NADH } (-0.32\text{ V}) \longrightarrow \text{Complex I} \longrightarrow \text{Q } (+0.045\text{ V}) \longrightarrow \text{Complex III} \longrightarrow \text{Cyt } c \ (+0.254\text{ V}) \longrightarrow \text{Complex IV} \longrightarrow \text{O}_2 \ (+0.816\text{ V})

Mitochondrial Electron Transport Chain Complexes & Proton Translocation:

 Intermembrane Space (IMS)   [4 H+]                 [4 H+]          [2 H+]
 ------------------------------^-----------------------^---------------^------
 Inner Membrane (IMM)          |                       |               |
                           Complex I      Q-Cycle  Complex III    Complex IV
                          (NADH:Q OR)  --> [Q] --> (Cyt bc1) --> [Cyt c] --> (Cyt c Oxidase)
                               ^            ^                                  |
                               |            |                                  v
 Matrix                     NADH + H+   Complex II                        1/2 O2 + 2 H+
                                       (Succinate:Q)                            |
                                            ^                                   v
                                       Succinate                              H2O

The Four Respiratory Complexes

  1. Complex I (NADH:Ubiquinone Oxidoreductase):

    • Massive L-shaped complex (45 subunits, Mr≈1,000 kDaM_r \approx 1,000\text{ kDa}) with one arm in the membrane and one extending into the matrix.
    • Accepts two electrons from NADH\text{NADH} via flavin mononucleotide (FMN), which then pass through a chain of 8−98-9 iron-sulfur centers ([2Fe−2S][2\text{Fe}-2\text{S}] and [4Fe−4S][4\text{Fe}-4\text{S}]) to reduce ubiquinone (Q) to ubiquinol (QH2\text{QH}_2).
    • Electron transfer drives conformational changes in long horizontal α\alpha-helices, pumping 4 H+4\text{ H}^+ per NADH across the IMM into the intermembrane space (IMS).
  2. Complex II (Succinate Dehydrogenase / Succinate:Ubiquinone Oxidoreductase):

    • The only membrane-bound enzyme of the TCA cycle; contains four subunits, covalently bound FAD, three Fe-S centers, and a cytochrome b560b_{560}.
    • Transfers electrons from succinate to FAD, through the Fe-S centers, to Q, forming QH2\text{QH}_2.
    • Because ΔE∘′\Delta E^{\circ\prime} between succinate (E∘′=+0.03 VE^{\circ\prime} = +0.03\text{ V}) and ubiquinone (+0.045 V+0.045\text{ V}) is very small (ΔG∘′≈−2.9 kJ/mol\Delta G^{\circ\prime} \approx -2.9\text{ kJ/mol}), no protons are pumped across the membrane at Complex II (0 H+0\text{ H}^+).
  3. Coenzyme Q (Ubiquinone / CoQ):

    • A hydrophobic benzoquinone attached to a long isoprenoid tail (10 units in humans: CoQ10\text{CoQ}_{10}), allowing it to diffuse rapidly within the lipid core of the IMM.
    • Acts as a mobile two-electron, two-proton carrier that collects reducing equivalents from Complex I, Complex II, electron-transferring flavoprotein (ETF:ubiquinone oxidoreductase from fatty acid β\beta-oxidation), and glycerol-3-phosphate dehydrogenase.
  4. Complex III (Cytochrome bc1bc_1 Complex / Ubiquinol:Cytochrome c Oxidoreductase):

    • A homodimer containing cytochrome bb (hemes bLb_L and bHb_H), the Rieske [2Fe−2S][2\text{Fe}-2\text{S}] protein, and cytochrome c1c_1.
    • Catalyzes the Q-Cycle: Because QH2\text{QH}_2 is an obligatory two-electron carrier and cytochrome c is an obligatory single-electron carrier (Fe3+↔Fe2+Fe^{3+} \leftrightarrow Fe^{2+}), the Q-cycle bifurcates electron flow. For every pair of electrons transferred to two molecules of cytochrome c, 4 H+4\text{ H}^+ are pumped into the IMS and two protons are taken up from the matrix.
  5. Cytochrome c:

    • A small, water-soluble peripheral hemeprotein (Mr≈12.4 kDaM_r \approx 12.4\text{ kDa}) located in the intermembrane space that ferries single electrons from Complex III to Complex IV.
  6. Complex IV (Cytochrome c Oxidase):

    • Homodimer (13 subunits per monomer) containing two heme groups (hemes aa and a3a_3) and two copper centers (binuclear CuA\text{Cu}_A and mononuclear CuB\text{Cu}_B).
    • Heme a3a_3 and CuB\text{Cu}_B form a binuclear center that coordinates and activates molecular oxygen (O2O_2): 4Cyt c(Fe2+)+8Hmatrix++O2⟶4Cyt c(Fe3+)+2H2O+4HIMS+4\text{Cyt } c (\text{Fe}^{2+}) + 8\text{H}^+_{\text{matrix}} + \text{O}_2 \longrightarrow 4\text{Cyt } c (\text{Fe}^{3+}) + 2\text{H}_2\text{O} + 4\text{H}^+_{\text{IMS}}
    • For every pair of electrons (1/2 O2O_2), 2 H+2\text{ H}^+ are pumped into the IMS, and two chemical protons from the matrix are consumed into H2OH_2O.

Total Proton Translocation Stoichiometry

  • Per mole of NADH\text{NADH}: 4 H+(Complex I)+4 H+(Complex III)+2 H+(Complex IV)=10 H+4\text{ H}^+ (\text{Complex I}) + 4\text{ H}^+ (\text{Complex III}) + 2\text{ H}^+ (\text{Complex IV}) = \mathbf{10\text{ H}^+} pumped into IMS.
  • Per mole of FADH2\text{FADH}_2: 0 H+(Complex II)+4 H+(Complex III)+2 H+(Complex IV)=6 H+0\text{ H}^+ (\text{Complex II}) + 4\text{ H}^+ (\text{Complex III}) + 2\text{ H}^+ (\text{Complex IV}) = \mathbf{6\text{ H}^+} pumped into IMS.

Chemiosmotic Hypothesis and the ATP Synthase Mechanism

Proposed by Peter Mitchell in 1961 (Nobel Prize, 1978), the chemiosmotic hypothesis established that the free energy of electron transport is conserved by pumping protons out of the matrix, establishing an electrochemical proton gradient termed the proton-motive force (Δp\Delta p):

Δp=Δψ−2.303RTFΔpH\Delta p = \Delta\psi - \frac{2.303 RT}{F}\Delta\text{pH}

Where:

  • Δψ\Delta\psi = electrical membrane potential across the IMM (≈160−180 mV\approx 160-180\text{ mV}, matrix negative).
  • ΔpH\Delta\text{pH} = chemical pH gradient (matrix is alkaline by ≈0.75−1.0 pH unit\approx 0.75-1.0\text{ pH unit}).
  • At physiological temperature (37∘C37^\circ\text{C} / 310 K310\text{ K}), 2.303RTF≈60 mV\frac{2.303 RT}{F} \approx 60\text{ mV}.
  • Total Proton-Motive Force: Δp≈170 mV+60 mV=220 to 230 mV\Delta p \approx 170\text{ mV} + 60\text{ mV} = \mathbf{220\text{ to } 230\text{ mV}} (directed inward toward the matrix).

ATP Synthase (FoF1F_oF_1 Complex) and Boyer's Rotational Catalysis

ATP synthase (Mr≈550 kDaM_r \approx 550\text{ kDa}) consists of two functional sectors:

  1. FoF_o Sector (Hydrophobic, Membrane-Spanning): Comprises a static aa subunit (containing two non-connecting proton half-channels) and a rotating ring of hydrophobic cc subunits (88 subunits in mammalian mitochondria). Each cc subunit bears a crucial carboxyl group (Asp-61 in E. coli or Glu-58 in animals) that binds a proton from the IMS half-channel, rotates through the lipid bilayer, and releases the proton into the matrix half-channel.
  2. F1F_1 Sector (Hydrophilic, Matrix-Facing Catalytic Head): Comprises an (αβ)3(\alpha\beta)_3 hexamer held stationary by a peripheral stator stalk (b2δb_2\delta). The central asymmetric γϵ\gamma\epsilon shaft is firmly fixed to the rotating cc-ring.
Paul Boyer's Binding-Change Mechanism for the Three Beta Subunits:

       [Open (O) State]        -----> Binds ADP + Pi loosely
              |
              v
      [Loose (L) State]        -----> Traps substrates in active site
              |
              v
      [Tight (T) State]        -----> Conformation forces condensation to ATP
              |
              v
       [Open (O) State]        -----> Releases newly formed ATP into matrix
  • Energy Requirement of ATP Synthesis: Paul Boyer's binding-change studies (begun in the 1970s; Nobel Prize 1997) showed that on the enzyme surface of the Tight (TT) subunit, the equilibrium constant for ADP+Pi⇌ATP+H2O\text{ADP} + \text{P}_i \rightleftharpoons \text{ATP} + \text{H}_2\text{O} is near unity (ΔG∘′≈0\Delta G^{\circ\prime} \approx 0). The enzyme binds ATP with such extraordinary affinity (Kd≈10−12 MK_d \approx 10^{-12}\text{ M}) that ATP forms spontaneously. The proton-motive force is NOT required to synthesize the phosphoanhydride bond; it is required to rotate the γ\gamma stalk and force open the TT subunit to release the bound ATP!
  • Rotation Stoichiometry: One full 360∘360^\circ rotation of the cc-ring rotates the γ\gamma stalk through all three β\beta subunits, releasing 3 ATP3\text{ ATP} molecules. In mammalian mitochondria with an 8-subunit8\text{-subunit} cc-ring, 8 H+8\text{ H}^+ are transported per 360∘360^\circ rotation, giving 8/3=2.67 H+8/3 = 2.67\text{ H}^+ per ATP synthesized.
  • Phosphate Import Cost: Import of Pi\text{P}_i into the matrix occurs via the electroneutral phosphate translocase (H2PO4−/H+\text{H}_2\text{PO}_4^- / \text{H}^+ symporter), consuming 1 H+1\text{ H}^+ per ATP. Export of ATP4−\text{ATP}^{4-} in exchange for ADP3−\text{ADP}^{3-} via the electrogenic adenine nucleotide translocase (ANT) consumes one unit of membrane potential (≈0.25 H+\approx 0.25\text{ H}^+ equivalent).
  • Total Proton Cost per ATP Exported: about 2.7 H+2.7\text{ H}^+ for synthesis plus about 1 H+1\text{ H}^+ for moving PiP_i, ADP, and ATP across the membrane, which standard P/O accounting rounds to 4 H+ per ATP\mathbf{4\text{ H}^+ \text{ per ATP}}.

Modern P/O Ratios and Net ATP Yield of Glucose Oxidation

P/O Ratio for NADH=10 H+ pumped4 H+ consumed per ATP=2.5 ATP\text{P/O Ratio for NADH} = \frac{10\text{ H}^+\text{ pumped}}{4\text{ H}^+\text{ consumed per ATP}} = \mathbf{2.5\text{ ATP}} P/O Ratio for FADH2=6 H+ pumped4 H+ consumed per ATP=1.5 ATP\text{P/O Ratio for FADH}_2 = \frac{6\text{ H}^+\text{ pumped}}{4\text{ H}^+\text{ consumed per ATP}} = \mathbf{1.5\text{ ATP}}

Mitochondrial Shuttles for Cytosolic NADH

Because the inner mitochondrial membrane is impermeable to NADH\text{NADH} and NAD+\text{NAD}^+, cytosolic NADH\text{NADH} from glycolysis enters mitochondria via two shuttle systems:

  1. Malate-Aspartate Shuttle (Liver, Kidney, Heart): Cytosolic NADH\text{NADH} reduces OAA to malate, which enters the matrix and is re-oxidized by mitochondrial malate dehydrogenase to generate matrix NADH\text{NADH}. Yields 2.5 ATP2.5\text{ ATP} per cytosolic NADH (Net: 32 ATP32\text{ ATP} per glucose).
  2. Glycerol-3-Phosphate Shuttle (Skeletal Muscle, Brain): Cytosolic NADH\text{NADH} reduces DHAP to glycerol-3-phosphate. Mitochondrial glycerol-3-phosphate dehydrogenase on the outer surface of the IMM transfers electrons to FAD, producing FADH2\text{FADH}_2, which enters the ETC at Coenzyme Q. Yields 1.5 ATP1.5\text{ ATP} per cytosolic NADH (Net: 30 ATP30\text{ ATP} per glucose).
Pathway StageDirect ProductPhosphorylation MechanismNet ATP (Glycerol-3-P Shuttle)Net ATP (Malate-Asp Shuttle)
Glycolysis2 ATP2\text{ ATP}Substrate-level2222
Glycolysis2 NADH2\text{ NADH}Oxidative via Shuttle2×1.5=32\times 1.5 = 32×2.5=52\times 2.5 = 5
Pyruvate Dehydrogenase2 NADH2\text{ NADH}Oxidative (Matrix)2×2.5=52\times 2.5 = 52×2.5=52\times 2.5 = 5
Citric Acid Cycle2 GTP / ATP2\text{ GTP / ATP}Substrate-level2222
Citric Acid Cycle6 NADH6\text{ NADH}Oxidative (Matrix)6×2.5=156\times 2.5 = 156×2.5=156\times 2.5 = 15
Citric Acid Cycle2 FADH22\text{ FADH}_2Oxidative (Matrix)2×1.5=32\times 1.5 = 32×1.5=32\times 1.5 = 3
Total Net Yield per Glucose——30 ATP30\text{ ATP}32 ATP32\text{ ATP}

Bioenergetic Pharmacology: Inhibitors and Uncouplers

AgentTarget / MechanismEffect on Electron Transport (O2O_2 consumption)Effect on ATP SynthesisEffect on Proton Gradient (Δp\Delta p)
Rotenone / AmytalBlocks Fe-S centers of Complex IInhibited (with NADH-linked substrates)InhibitedCollapses
MalonateCompetitive inhibitor of Complex II (Succinate DH)Inhibited (with succinate substrate)InhibitedCollapses
Antimycin ABlocks QiQ_i site of Complex III (Cytochrome bc1bc_1)InhibitedInhibitedCollapses
Cyanide (CN−\text{CN}^-), Carbon Monoxide (CO), Azide (N3−\text{N}_3^-)Binds tightly to Fe3+/Fe2+Fe^{3+}/Fe^{2+} heme a3a_3 and CuB\text{Cu}_B of Complex IVCompletely BlockedCompletely BlockedCollapses completely
OligomycinBinds cc-ring / stalk of FoF_o sector, blocking proton channelInhibited (due to high backpressure of Δp\Delta p)InhibitedMarkedly Increases
2,4-Dinitrophenol (DNP), FCCPLipophilic protonophores (Uncouplers); shuttles H+\text{H}^+ across IMMMaximally AcceleratedCompletely BlockedAbolished (Energy dissipated as heat)
Thermogenin (UCP-1)Physiological uncoupling protein in brown adipose tissueAcceleratedDecreasedDissipated into non-shivering thermogenesis
Atractyloside / Bongkrekic AcidInhibits Adenine Nucleotide Translocase (ANT)InhibitedInhibitedIncreases

PRC Board Exam Distinguishing Criterion: To differentiate an ATP synthase inhibitor (oligomycin) from an ETC complex inhibitor (cyanide): adding an uncoupler like DNP to an oligomycin-inhibited system restores rapid oxygen consumption (because the ETC machinery is intact; it was merely halted by excessive proton back-pressure). Adding DNP to a cyanide-inhibited system has zero effect because Complex IV is physically poisoned.


Lipid Catabolism: Activation, Carnitine Shuttle, and β\beta-Oxidation

Triacylglycerols stored in adipocytes are mobilized by hormone-sensitive lipase (HSL) and adipose triglyceride lipase (ATGL) in response to glucagon and epinephrine (via cAMP/PKA phosphorylation), releasing free fatty acids into the bloodstream bound to serum albumin.

1. Fatty Acid Activation

In the cytosol, fatty acids are activated to fatty acyl-CoA by fatty acyl-CoA synthetase (thiokinase) located on the outer mitochondrial membrane:

Fatty Acid+ATP+CoA-SH⇌Mg2+Acyl-CoA+AMP+PPi\text{Fatty Acid} + \text{ATP} + \text{CoA-SH} \xrightleftharpoons{\text{Mg}^{2+}} \text{Acyl-CoA} + \text{AMP} + \text{PP}_i PPi+H2O→Pyrophosphatase2Pi(ΔG∘′=−19 kJ/mol)\text{PP}_i + \text{H}_2\text{O} \xrightarrow{\text{Pyrophosphatase}} 2\text{P}_i \quad (\Delta G^{\circ\prime} = -19\text{ kJ/mol})

Net Activation: Fatty Acid+ATP+CoA-SH⟶Acyl-CoA+AMP+2Pi(ΔG∘′=−34 kJ/mol)\text{Net Activation: } \text{Fatty Acid} + \text{ATP} + \text{CoA-SH} \longrightarrow \text{Acyl-CoA} + \text{AMP} + 2\text{P}_i \quad (\Delta G^{\circ\prime} = -34\text{ kJ/mol})

Notice that activation consumes two high-energy phosphate bonds (ATP→AMP+2PiATP \rightarrow AMP + 2P_i), equivalent to spending 2 ATP2\text{ ATP}.

2. The Carnitine Shuttle (Rate-Limiting Translocation Step)

While the outer mitochondrial membrane is permeable to acyl-CoA, the inner mitochondrial membrane is strictly impermeable to CoA esters. Long-chain acyl-CoA (>12 carbons>12\text{ carbons}) must use the carnitine shuttle:

The Carnitine Shuttle System:
  Outer Mitochondrial Membrane (OMM): 
     Fatty Acyl-CoA + Carnitine  ====(CPT-I)====>  Fatty Acylcarnitine + CoA-SH
                                                          |
  Intermembrane Space (IMS)                               v
  Inner Mitochondrial Membrane (IMM):       [Carnitine-Acylcarnitine Translocase]
                                                          |
  Mitochondrial Matrix:                                   v
     Fatty Acylcarnitine + CoA-SH  ====(CPT-II)====>  Fatty Acyl-CoA + Carnitine
  • Carnitine Palmitoyltransferase I (CPT-I / CAT-I): Resides on the outer mitochondrial membrane; catalyzes the transfer of the fatty acyl group from CoA to the hydroxyl group of carnitine, forming fatty acylcarnitine.
  • Allosteric Regulation by Malonyl-CoA: CPT-I is potently inhibited by malonyl-CoA, the first committed intermediate in fatty acid biosynthesis. When the liver is actively synthesizing fatty acids from carbohydrates, malonyl-CoA levels rise, shutting down CPT-I and preventing newly synthesized fatty acids from entering mitochondria to be degraded (preventing a futile cycle).
  • Carnitine-Acylcarnitine Translocase: An antiporter in the IMM that moves acylcarnitine into the matrix while exporting free carnitine back to the intermembrane space.
  • Carnitine Palmitoyltransferase II (CPT-II): Located on the inner surface of the IMM; transfers the acyl group back onto matrix CoA, regenerating fatty acyl-CoA and free carnitine.

3. The 4-Step β\beta-Oxidation Spiral

Inside the matrix, fatty acyl-CoA is degraded through a repeating sequence of four enzymatic reactions that cleaves two carbons as acetyl-CoA per turn:

The Four-Step Beta-Oxidation Spiral:
  R-CH2-CH2-CH2-CO-SCoA  (Fatty Acyl-CoA)
         |
         v  [Step 1: Acyl-CoA Dehydrogenase]  --> FAD to FADH2 (1.5 ATP)
  R-CH2-CH=CH-CO-SCoA    (trans-Δ2-Enoyl-CoA)
         |
         v  [Step 2: Enoyl-CoA Hydratase]     --> H2O Added
  R-CH2-CH(OH)-CH2-CO-SCoA (L-β-Hydroxyacyl-CoA)
         |
         v  [Step 3: β-Hydroxyacyl-CoA DH]    --> NAD+ to NADH (2.5 ATP)
  R-CH2-CO-CH2-CO-SCoA   (β-Ketoacyl-CoA)
         |
         v  [Step 4: β-Ketothiolase]          --> CoA-SH added (Cleavage)
  R-CH2-CO-SCoA (Shortened by 2C)  +  CH3-CO-SCoA (Acetyl-CoA to TCA)
  1. Step 1: Oxidation (Dehydrogenation): Acyl-CoA dehydrogenase introduces a trans double bond between C2 (α\alpha) and C3 (β\beta), transferring electrons to enzyme-bound FAD, which passes them to ubiquinone via electron-transferring flavoprotein (ETF). Yields 1 FADH21\text{ FADH}_2 (1.5 ATP1.5\text{ ATP}).
  2. Step 2: Hydration: Enoyl-CoA hydratase stereospecifically adds water across the trans-Δ2\Delta^2 double bond, yielding L-β-hydroxyacyl-CoA\text{L-}\beta\text{-hydroxyacyl-CoA}.
  3. Step 3: Oxidation: L-β-hydroxyacyl-CoA dehydrogenase\text{L-}\beta\text{-hydroxyacyl-CoA dehydrogenase} oxidizes the β\beta-hydroxyl group to a β\beta-keto group, reducing NAD+\text{NAD}^+ to NADH+H+\text{NADH} + \text{H}^+. Yields 1 NADH1\text{ NADH} (2.5 ATP2.5\text{ ATP}).
  4. Step 4: Thiolytic Cleavage (Thiolysis): β-ketothiolase\beta\text{-ketothiolase} uses a free Coenzyme A molecule to cleave the bond between Cα\text{C}_\alpha and Cβ\text{C}_\beta, releasing acetyl-CoA and a fatty acyl-CoA shortened by two carbons.

Comprehensive Stoichiometric Calculation for Palmitate (C16C_{16})

Palmitic acid (C16H32O2C_{16}H_{32}O_2) requires 7 cycles of β\beta-oxidation and produces 8 molecules of acetyl-CoA:

Palmitoyl-CoA+7CoA-SH+7FAD+7NAD++7H2O⟶8Acetyl-CoA+7FADH2+7NADH+7H+\text{Palmitoyl-CoA} + 7\text{CoA-SH} + 7\text{FAD} + 7\text{NAD}^+ + 7\text{H}_2\text{O} \longrightarrow 8\text{Acetyl-CoA} + 7\text{FADH}_2 + 7\text{NADH} + 7\text{H}^+

  • From 7 FADH2\text{FADH}_2: 7×1.5 ATP=10.5 ATP7 \times 1.5\text{ ATP} = \mathbf{10.5\text{ ATP}}
  • From 7 NADH\text{NADH}: 7×2.5 ATP=17.5 ATP7 \times 2.5\text{ ATP} = \mathbf{17.5\text{ ATP}}
  • From 8 Acetyl-CoA\text{Acetyl-CoA} (via TCA Cycle):
    • Each Acetyl-CoA yields: 3 NADH×2.5=7.5 ATP3\text{ NADH} \times 2.5 = 7.5\text{ ATP}, 1 FADH2×1.5=1.5 ATP1\text{ FADH}_2 \times 1.5 = 1.5\text{ ATP}, and 1 GTP=1.0 ATP1\text{ GTP} = 1.0\text{ ATP} (Total = 10.0 ATP10.0\text{ ATP} per Acetyl-CoA).
    • 8×10.0 ATP=80.0 ATP8 \times 10.0\text{ ATP} = \mathbf{80.0\text{ ATP}}
  • Gross ATP Produced: 10.5+17.5+80.0=108.0 ATP10.5 + 17.5 + 80.0 = \mathbf{108.0\text{ ATP}}
  • Activation Cost: Spent during conversion to palmitoyl-CoA (ATP→AMP+2PiATP \rightarrow AMP + 2P_i) = −2.0 ATP\mathbf{-2.0\text{ ATP}}

Net ATP Yield of Palmitate=108.0−2.0=106 ATP\mathbf{Net\ ATP\ Yield\ of\ Palmitate} = 108.0 - 2.0 = \mathbf{106\text{ ATP}}

Notice that older textbooks using obsolete P/O ratios of 3 for NADH and 2 for FADH2 report 129 ATP. Licensure exams require the modern, experimentally validated value of 106 ATP.


Ketone Body Metabolism: Ketogenesis and Ketolysis

During prolonged fasting, starvation, or uncontrolled Type 1 Diabetes Mellitus, carbohydrate availability is severely restricted. Adipose lipolysis floods the liver with free fatty acids, accelerating β\beta-oxidation and producing enormous amounts of acetyl-CoA. Concurrently, hepatic oxaloacetate is drained to sustain gluconeogenesis. Because oxaloacetate levels are depleted, excess acetyl-CoA cannot enter the citric acid cycle. The liver shunts this excess acetyl-CoA into ketone bodies:

  1. Acetoacetate
  2. D-β\beta-Hydroxybutyrate (technically a hydroxy acid, but classified metabolically as a ketone body)
  3. Acetone (metabolically inert volatile byproduct released via the lungs; causes the characteristic "fruity breath" of diabetic ketoacidosis)

Pathway of Hepatic Ketogenesis (Mitochondrial Matrix)

  1. Thiolase: Two molecules of acetyl-CoA condense: 2Acetyl-CoA⇌Acetoacetyl-CoA+CoA-SH2\text{Acetyl-CoA} \rightleftharpoons \text{Acetoacetyl-CoA} + \text{CoA-SH}.
  2. HMG-CoA Synthase (Mitochondrial): Rate-limiting enzyme of ketogenesis; condenses acetoacetyl-CoA with a third acetyl-CoA to form β\beta-hydroxy-β\beta-methylglutaryl-CoA (HMG-CoA).
  3. HMG-CoA Lyase: Cleaves HMG-CoA to release acetoacetate and acetyl-CoA.
  4. β\beta-Hydroxybutyrate Dehydrogenase: Interconverts acetoacetate and D-β-hydroxybutyrate\text{D-}\beta\text{-hydroxybutyrate} in an NADH\text{NADH}-dependent equilibrium. A high matrix [NADH]/[NAD+][\text{NADH}]/[\text{NAD}^+] ratio (as in active β\beta-oxidation) heavily favors β\beta-hydroxybutyrate.

Extrahepatic Ketolysis (Ketone Body Utilization)

Ketone bodies are released into the blood and taken up by extrahepatic tissues (cardiac muscle, skeletal muscle, renal cortex, and during starvation, the brain, which adapts to derive >60%>60\% of its ATP from ketone bodies):

  1. D-β-hydroxybutyrate\text{D-}\beta\text{-hydroxybutyrate} is oxidized to acetoacetate by β\beta-hydroxybutyrate dehydrogenase, producing 1 NADH1\text{ NADH}.
  2. Acetoacetate is activated to acetoacetyl-CoA by succinyl-CoA:acetoacetate CoA-transferase (Thiophorase): Acetoacetate+Succinyl-CoA→ThiophoraseAcetoacetyl-CoA+Succinate\text{Acetoacetate} + \text{Succinyl-CoA} \xrightarrow{\text{Thiophorase}} \text{Acetoacetyl-CoA} + \text{Succinate}
  3. Thiolase cleaves acetoacetyl-CoA with CoA-SH to produce 2 Acetyl-CoA2\text{ Acetyl-CoA}, which enter the TCA cycle.

PRC Licensure High-Yield Principle: Why can't the liver utilize ketone bodies as fuel? The liver completely lacks succinyl-CoA transferase (thiophorase). The liver produces ketone bodies exclusively for export to other tissues; it cannot consume them itself, preventing futile cycles.

Loading diagram...
Mitochondrial Respiratory Chain and Inhibitor Sites
Test Your Knowledge

A suspension of freshly isolated, intact rat liver mitochondria is supplied with pyruvate, malate, ADP, and inorganic phosphate, demonstrating robust oxygen consumption and ATP synthesis. Adding Compound X completely stops both oxygen consumption and ATP synthesis. Subsequent addition of 2,4-dinitrophenol (DNP) restores rapid oxygen consumption without restoring ATP synthesis. Adding Compound Y instead halts both processes, but adding DNP produces no recovery of oxygen consumption. What are the identities of Compounds X and Y?

A

Compound X is cyanide (inhibiting Complex IV), and Compound Y is rotenone (inhibiting Complex I)

B

Compound X is 2,4-dinitrophenol (an uncoupler), and Compound Y is atractyloside (inhibiting ANT)

C

Compound X is oligomycin (inhibiting the Fo proton channel of ATP synthase), and Compound Y is cyanide (inhibiting Complex IV)

D

Compound X is antimycin A (inhibiting Complex III), and Compound Y is oligomycin (inhibiting ATP synthase)

Test Your Knowledge

Calculate the theoretical net ATP yield obtained from the complete aerobic oxidation of one mole of palmitic acid (C16H32O2) to CO2 and H2O, utilizing standard modern P/O ratios (2.5 for NADH and 1.5 for FADH2) and accounting for the initial activation step.

A

120 moles of ATP

B

106 moles of ATP

C

98 moles of ATP

D

129 moles of ATP

Test Your Knowledge

Which statement correctly describes the biochemical mechanism of carnitine palmitoyltransferase I (CPT-I) and its physiological regulation in hepatocytes?

A

CPT-I is a cytosolic matrix-facing translocase that requires pyridoxal phosphate to exchange acetyl-CoA for carnitine

B

CPT-I catalyzes the ATP-dependent cleavage of triacylglycerols in adipose tissue and is inactivated by protein kinase A phosphorylation

C

CPT-I is an outer mitochondrial membrane enzyme that forms acylcarnitine and is inhibited by malonyl-CoA

D

CPT-I is an inner mitochondrial membrane enzyme activated by high levels of glucagon and inhibited by citrate

Sections you finish are checked off in the contents.